[Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study].
Nan Fang Yi Ke Da Xue Xue Bao / Journal of Southern Medical University · 2008-03-01 · Randomised trial
Abstract
OBJECTIVE: To evaluate the efficacy of 3 commonly used protocols for management of acute exacerbation of asthma in children. METHODS: Totally 113 asthmatic children were randomized into 3 groups. In group A (53 cases), the children were treated with inhalation of nebulized budesonide suspension plus salbutamol and ipratropium bromide twice daily for 5 days; in group B (41 cases), budesonide plus salbutamol and ipratropium aerosol was administered, and in group C (29 cases), dexathmisone plus aminophylline injection was given once daily for 5 days. All the children received basic treatment with fluid infusion, antibiotics or/and anti-virus medications. RESULTS: The children in both groups A and C showed effectively controlled asthma attack, with significant differences in the therapeutic effects (P>0.05). In contrast, only a few children showed improvement in group B, suggesting the ineffectiveness of the treatment. CONCLUSION: Nebulized medicine is one of the best means for management of acute asthma exacerbation in children, and inhalation of budesonide suspension plus salbutamol and ipratropium bromide can effectively relieve the asthmatic symptoms in these children with good compliance and convenient administration.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Children · Inhaled corticosteroids · Ipratropium · Respiratory drugs · Salbutamol
Related articles
- Effects of nebulized budesonide as an adjunct to standard treatment of asthma exacerbations: a randomized, double-blind, placebo-controlled trial. (Mymensingh Med J, 2014)
- Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics. (Ital J Pediatr, 2018)
- Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. (Cochrane Database Syst Rev, 2014)
- Guideline for the management of acute asthma in children: 2013 update. (S Afr Med J, 2013)
- Effects of nebulized budesonide plus salbutamol and nebulized salbutamol monotherapy on mild to moderate acute exacerbation of asthma in children: A comparative study. (J Pak Med Assoc, 2021)
- Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma. (J Pak Med Assoc, 2016)